Form D · Other Health Care
Fuse Oncology, Inc.
Greensboro, NC · CIK 0001931320
Offering snapshot reported Apr 21, 2023 · SEC filing
- Reported sold
- $8.86M Offering amount: $9.69M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2023 | Initial | $8,859,474 | No comparison | 20 | SEC filing |
| May 27, 2022 | Initial | $2,951,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479689
Source: Form D, filed Apr 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Bauler | Director, Executive |
| Jay Brennan | Director |
| John Miller | Director |
| Benjamin Sintay | Executive |
| John Strider | Executive |
| David Wiant | Executive |
| David Wiantt | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4214 West Wendover Ave. #1340
Greensboro, NC, 27407
Greensboro, NC, 27407